ArticleStroke (Hoboken, N.J.)2022
Long-Term Outcome and Quality of Life in Patients With Stroke Presenting With Extensive Early Infarction.
Article in Stroke (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Long-Term (12 Months) Outcomes of Endovascular Thrombectomy for Large Core Stroke: A Meta-Analysis of SELECT2, TESLA, TENSION, and LASTE Trials.AJNR. American journal of neuroradiology · 2025Pooled it
- Virtual reality for stroke rehabilitation.The Cochrane database of systematic reviews · 2025Pooled it
- Perfusion Abnormalities on 24-Hour Perfusion Imaging in Patients With Complete Endovascular Reperfusion.Stroke · 2024Article
- Long-Term Effect of Mechanical Thrombectomy in Stroke Patients According to Advanced Imaging Characteristics.Clinical neuroradiology · 2024Article
- Functional long-term outcome following endovascular thrombectomy in patients with acute ischemic stroke.Neurological research and practice · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The benefit of mechanical thrombectomy in patients with low Alberta Stroke Program Early Computed Tomography Score (ASPECTS) for short-term outcomes is debatable and long-term outcomes remain unknown. This retrospective, monocentric cohort study aimed to assess the association between reperfusion grade and the long-term functional outcome measured with modified Rankin scale as well as the long-term health-related quality of life recorded at the last follow-up in patients according to baseline ASPECTS (0-5 versus 6-10). Methods: Deceased patients were identified from the Swiss population register and follow-up telephone interviews were conducted with all surviving patients with stroke treated with mechanical thrombectomy between January 1, 2010, and December 31, 2018. Favorable outcome was defined as modified Rankin scale 0 to 3; health-related quality of life was assessed using the 3-level version of the EuroQol 5-dimensional questionnaire. The EuroQol 5-dimension utility index was calculated for statistical analyses. The reperfusion grade was core laboratory adjudicated using the expanded treatment in cerebral ischemia score. Adjusted odds ratios for the association between the reperfusion grade assessed by expanded treatment in cerebral ischemia and outcomes were calculated from multivariable logistic regression. Results: Of the 1114 patients with available long-term follow-up records (median follow-up, 3.67 years), 997 were included in the final analysis. Respectively, patients with low ASPECTS more often had complaints regarding mobility (67.1% versus 42.1%, Conclusion: Despite low baseline ASPECTS, a higher reperfusion grade results in better functional outcomes and may improve health-related quality of life in the long term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.